{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:27:35Z","timestamp":1787506055728,"version":"build-2736575974"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejmech.2023.115301","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T12:52:32Z","timestamp":1679489552000},"page":"115301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluation"],"prefix":"10.1016","volume":"252","author":[{"given":"Filip","family":"Pidany","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Kroustkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Al Mamun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Suchankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Brazzolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Nachon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Chantegreil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Dolezal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka","family":"Pulkrabkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubica","family":"Muckova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Hrabinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Finger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Kufa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Soukup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Jun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaroslav","family":"Jenco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Kunes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Novakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6977-7596","authenticated-orcid":false,"given":"Jan","family":"Korabecny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1555-8870","authenticated-orcid":false,"given":"Lucie","family":"Cahlikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115301_bib1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2014.11.011","article-title":"Review of human butyrylcholinesterase structure, function, genetic variants, history of use in the clinic, and potential therapeutic uses","volume":"148","author":"Lockridge","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejmech.2023.115301_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","article-title":"Butyrylcholinesterase as a prognostic marker: a review of the literature","volume":"4","author":"Santarpia","year":"2013","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.ejmech.2023.115301_bib3","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2006.11.005","article-title":"A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India","volume":"378","author":"Manoharan","year":"2007","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ejmech.2023.115301_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/bi00052a003","article-title":"Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity","volume":"32","author":"Vellom","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.115301_bib5","doi-asserted-by":"crossref","first-page":"17083","DOI":"10.1016\/S0021-9258(19)85305-X","article-title":"Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket","volume":"268","author":"Ordentlich","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib6","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/med.21745","article-title":"Structure and therapeutic uses of butyrylcholinesterase: application in detoxification, Alzheimer's disease, and fat metabolism","volume":"41","author":"Xing","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.115301_bib7","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1080\/13880209.2022.2102657","article-title":"Aaptamine \u2013 a dual acetyl \u2013 and butyrylcholinesterase inhibitor as potential anti-Alzheimer\u2019s disease agent","volume":"60","author":"Miao","year":"2022","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2023.115301_bib8","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib9","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib10","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.3390\/molecules22071145","article-title":"Therapeutic delivery of butyrylcholinesterase by brain-wide viral gene transfer to mice","volume":"22","author":"Gao","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2023.115301_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clinbiochem.2005.04.008","article-title":"Relationship between serum butyrylcholinesterase and the metabolic syndrome","volume":"38","author":"Randell","year":"2005","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ejmech.2023.115301_bib12","first-page":"1","article-title":"Novel inhibitors with sulfamethazine backbone: synthesis and biological study of multi-target cholinesterases and \u03b1-glucosidase inhibitors","author":"T\u00fcrke\u015f","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115301_bib13","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.nbd.2015.04.008","article-title":"The role of type 2 diabetes in neurodegeneration","volume":"84","author":"Verdile","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmech.2023.115301_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114248","article-title":"From tryptophan-based amides to tertiary amines: optimization of a butyrylcholinesterase inhibitor series","volume":"234","author":"Meden","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib15","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.toxlet.2017.11.029","article-title":"Bioscavenger is effective as a delayed therapeutic intervention following percutaneous VX poisoning in the Guinea-pig","volume":"293","author":"Mann","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.ejmech.2023.115301_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.21886","article-title":"Human butyrylcholinesterase efficacy against nerve agent exposure","volume":"31","author":"Reed","year":"2017","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejmech.2023.115301_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.109996","article-title":"Strategies for developing a recombinant butyrylcholinesterase medical countermeasure for organophosphorus poisoning","volume":"363","author":"Allard","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115301_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.3389\/fphar.2018.00112","article-title":"Treating cocaine addiction, obesity, and emotional disorders by viral gene transfer of butyrylcholinesterase","volume":"9","author":"Brimijoin","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115301_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0376-8716(97)00119-1","article-title":"Enhancing cocaine metabolism with butyrylcholinesterase as a treatment strategy","volume":"48","author":"Gorelick","year":"1997","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ejmech.2023.115301_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s11062-020-09864-3","article-title":"Butyrylcholinesterase in substance abuse: an overview","volume":"52","author":"Nurulain","year":"2020","journal-title":"Neurophysiology"},{"key":"10.1016\/j.ejmech.2023.115301_bib21","doi-asserted-by":"crossref","first-page":"6856","DOI":"10.1021\/acs.jmedchem.1c00167","article-title":"Highly potent and selective butyrylcholinesterase inhibitors for cognitive improvement and neuroprotection","volume":"64","author":"Li","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib22","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/1389203720666191107094949","article-title":"Butyrylcholinesterase: a multifaceted pharmacological target and tool","volume":"21","author":"Ha","year":"2020","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.ejmech.2023.115301_bib23","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cbi.2016.02.013","article-title":"Physiological roles for butyrylcholinesterase: a BChE-ghrelin axis","volume":"259","author":"Brimijoin","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2023.115301_bib24","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1073\/pnas.1421536112","article-title":"Plasma butyrylcholinesterase regulates ghrelin to control aggression","volume":"112","author":"Chen","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115301_bib25","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib26","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13195-022-01055-y","article-title":"Perspectives and challenges in patient stratification in Alzheimer's disease","volume":"14","author":"Abdelnour","year":"2022","journal-title":"Alzheimer's Res. Ther."},{"key":"10.1016\/j.ejmech.2023.115301_bib27","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1021\/acs.jmedchem.2c00399","article-title":"Rational design of a theranostic agent triggered by endogenous nitric oxide in a cellular model of Alzheimer's disease","volume":"65","author":"Lu","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib28","unstructured":"WHO, https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/dementia (Accessed 13 March 2023)."},{"key":"10.1016\/j.ejmech.2023.115301_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019","volume":"7","year":"2022","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.ejmech.2023.115301_bib30","series-title":"The Worldwide Costs of Dementia in 2019","first-page":"1","author":"Wimo","year":"2023"},{"key":"10.1016\/j.ejmech.2023.115301_bib31","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"Selective loss of central cholinergic neurons in Alzheimer's disease","volume":"308","author":"Davies","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115301_bib32","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.jalz.2019.09.075","article-title":"The path forward in Alzheimer's disease therapeutics: reevaluating the amyloid cascade hypothesis","volume":"16","author":"Tolar","year":"2019","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.ejmech.2023.115301_bib33","first-page":"673","article-title":"Global structure of the intrinsically disordered protein Tau emerges from its local structure","volume":"2","author":"Stelzl","year":"2022","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2023.115301_bib34","doi-asserted-by":"crossref","first-page":"10294","DOI":"10.1021\/acs.inorgchem.2c00502","article-title":"Azo-Stilbene and Pyridine\u2013Amine hybrid multifunctional molecules to target metal-mediated neurotoxicity and amyloid-\u03b2 aggregation in Alzheimer's disease","volume":"61","author":"Rana","year":"2022","journal-title":"Inorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib35","doi-asserted-by":"crossref","first-page":"11365","DOI":"10.1021\/acs.jmedchem.2c00944","article-title":"N-Benzyl benzamide derivatives as selective sub-nanomolar butyrylcholinesterase inhibitors for possible treatment in advanced Alzheimer's disease","volume":"65","author":"Du","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/srep39495","article-title":"Development of an in-vivo active reversible butyrylcholinesterase inhibitor","volume":"6","author":"Ko\u0161ak","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115301_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113397","article-title":"Discovery of multifunctional anti-Alzheimer\u2019s agents with a unique mechanism of action including inhibition of the enzyme butyrylcholinesterase and \u03b3-aminobutyric acid transporters","volume":"218","author":"Pasieka","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114510","article-title":"A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement","volume":"239","author":"Li","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib39","doi-asserted-by":"crossref","first-page":"19764","DOI":"10.1039\/D2RA03081K","article-title":"Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase","volume":"12","author":"Obaid","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2023.115301_bib40","doi-asserted-by":"crossref","first-page":"10030","DOI":"10.1021\/acs.jmedchem.0c01129","article-title":"Discovery and biological evaluation of a novel highly potent selective butyrylcholinsterase inhibitor","volume":"63","author":"Li","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib41","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2023.115301_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3390\/biom10050800","article-title":"Amaryllidaceae alkaloids of belladine-type from Narcissus pseudonarcissus cv. Carlton as new selective inhibitors of butyrylcholinesterase","volume":"10","author":"Al Mamun","year":"2020","journal-title":"Biomolecules"},{"key":"10.1016\/j.ejmech.2023.115301_bib43","doi-asserted-by":"crossref","first-page":"8308","DOI":"10.3390\/ijms22158308","article-title":"Amaryllidaceae alkaloids of norbelladine-type as inspiration for development of highly selective butyrylcholinesterase inhibitors: synthesis, biological activity evaluation, and docking studies","volume":"22","author":"Mamun","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115301_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115301_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3389\/fnagi.2018.00003","article-title":"Ethnopharmacological approaches for dementia therapy and significance of natural products and herbal drugs","volume":"10","author":"Tewari","year":"2018","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ejmech.2023.115301_bib46","article-title":"Formulation and evaluation of nasal insert for nose-to-brain drug delivery of rivastigmine tartrate","volume":"76","author":"Shaghlil","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejmech.2023.115301_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","article-title":"A new and rapid colorimetric determination of acetylcholinesterase activity","volume":"7","author":"Ellman","year":"1961","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115301_bib48","doi-asserted-by":"crossref","first-page":"9824","DOI":"10.1021\/acs.jmedchem.9b01220","article-title":"The blood\u2013brain barrier (BBB) score","volume":"62","author":"Gupta","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib49","doi-asserted-by":"crossref","DOI":"10.1021\/jm000986n","article-title":"Multiple-conformation and protonation-state representation in 4D-QSAR: the Neurokinin-1 receptor system","volume":"43","author":"Vedani","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib50","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1021\/jm011005p","article-title":"5D-QSAR: the key for simulating induced fit?","volume":"45","author":"Vedani","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib51","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1021\/jm050185q","article-title":"Combining protein modeling and 6D-QSAR. Simulating the binding of structurally diverse ligands to the estrogen receptor","volume":"48","author":"Vedani","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib52","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.2174\/092986709788803286","article-title":"Receptor dependent multidimensional QSAR for modeling drug--receptor interactions","volume":"16","author":"Polanski","year":"2009","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib53","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1021\/jm00042a006","article-title":"Genetically evolved receptor models: a computational approach to construction of receptor models","volume":"37","author":"Walters","year":"1994","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1021\/ci00020a020","article-title":"Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships","volume":"34","author":"Rogers","year":"1994","journal-title":"J. Chem. Inf. Comput. Sci."},{"key":"10.1016\/j.ejmech.2023.115301_bib55","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/1521-3838(200210)21:4<382::AID-QSAR382>3.0.CO;2-L","article-title":"Multidimensional QSAR: moving from three- to five-dimensional concepts","volume":"21","author":"Vedani","year":"2002","journal-title":"Quant. Struct.-Act. Relat."},{"key":"10.1016\/j.ejmech.2023.115301_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0223-5234(03)00012-6","article-title":"High throughput artificial membrane permeability assay for blood\u2013brain barrier","volume":"38","author":"Di","year":"2003","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib57","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.talanta.2009.12.052","article-title":"Colorimetric dipstick for assay of organophosphate pesticides and nerve agents represented by paraoxon, sarin and VX","volume":"81","author":"Pohanka","year":"2010","journal-title":"Talanta"},{"key":"10.1016\/j.ejmech.2023.115301_bib58","doi-asserted-by":"crossref","first-page":"16882","DOI":"10.3390\/ijms140816882","article-title":"Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study","volume":"14","author":"Sepsova","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115301_bib59","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1046\/j.0014-2956.2001.02692.x","article-title":"Engineering of a monomeric and low-glycosylated form of human butyrylcholinesterase: expression, purification, characterization and crystallization","volume":"269","author":"Nachon","year":"2002","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.ejmech.2023.115301_bib60","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1111\/j.1742-4658.2012.08672.x","article-title":"Human butyrylcholinesterase produced in insect cells: huprine-based affinity purification and crystal structure","volume":"279","author":"Brazzolotto","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2023.115301_bib61","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1107\/S0907444911007773","article-title":"Data processing and analysis with the autoPROC toolbox","volume":"67","author":"Vonrhein","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115301_bib62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1107\/S2059798319011471","article-title":"Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix","volume":"75","author":"Liebschner","year":"2019","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"10.1016\/j.ejmech.2023.115301_bib63","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/pro.3791","article-title":"Current developments in coot for macromolecular model building of electron Cryo-microscopy and crystallographic data","volume":"29","author":"Casa\u00f1al","year":"2020","journal-title":"Protein Sci."},{"key":"10.1016\/j.ejmech.2023.115301_bib64","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1107\/S0907444909029436","article-title":"Electronic ligand builder and optimization workbench (eLBOW): a tool for ligand coordinate and restraint generation","volume":"65","author":"Moriarty","year":"2009","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115301_bib65","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.1080\/07391102.2021.1957716","article-title":"Accuracy and precision of binding free energy prediction for a tacrine related lead inhibitor of acetylcholinesterase with an arsenal of supercomputerized molecular modelling methods: a comparative study","volume":"40","author":"Dolezal","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ejmech.2023.115301_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113112","article-title":"2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease","volume":"211","author":"Mezeiova","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115301_bib67","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1039\/C4MD00301B","article-title":"Tetrazole regioisomers in the development of nitro group-containing antitubercular agents","volume":"6","author":"Karabanovich","year":"2015","journal-title":"MedChemComm"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:52:28Z","timestamp":1759330348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":67,"alternative-id":["S0223523423002672"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115301","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly selective butyrylcholinesterase inhibitors related to Amaryllidaceae alkaloids - Design, synthesis, and biological evaluation","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115301","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115301"}}